Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
333M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
62.6M
-
Shares change
-
+2M
-
Total reported value, excl. options
-
$83.9M
-
Value change
-
+$2.48M
-
Put/Call ratio
-
0.29
-
Number of buys
-
49
-
Number of sells
-
-62
-
Price
-
$1.34
Significant Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q4 2023
157 filings reported holding PGEN - PRECIGEN, INC. - Common Stock as of Q4 2023.
PRECIGEN, INC. - Common Stock (PGEN) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.6M shares
of 333M outstanding shares and own 18.82% of the company stock.
Largest 10 shareholders include Patient Capital Management, LLC (16M shares), BlackRock Inc. (11.1M shares), VANGUARD GROUP INC (6.75M shares), GEODE CAPITAL MANAGEMENT, LLC (3.02M shares), MILLENNIUM MANAGEMENT LLC (2.85M shares), STATE STREET CORP (2.68M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (2M shares), JPMORGAN CHASE & CO (1.34M shares), MORGAN STANLEY (1.26M shares), and NORTHERN TRUST CORP (1.08M shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.